RankingsPricing
  1. JP-listed companies
  2. Carna Biosciences, Inc.
  3. Financials
  4. Net income

Carna Biosciences, Inc.JP:4572

Market cap
¥7.9B
P/E ratio
-3.7x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Dec 31, 2024-2,179+88.97%
Dec 31, 2023-1,153-14.57%
Dec 31, 2022-1,350+152.50%
Dec 31, 2021-534-51.89%
Dec 31, 2020-1,111-234.14%
Dec 31, 2019828-168.42%
Dec 31, 2018-1,211+64.20%
Dec 31, 2017-737+154.28%
Dec 31, 2016-290-163.53%
Dec 31, 2015456-153.90%
Dec 31, 2014-847+199.89%
Dec 31, 2013-282-37.26%
Dec 31, 2012-450+24.43%
Dec 31, 2011-362

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)